Company to Unveil Innovative Upgrades for Quell Wearable Pain Relief Technology LAS VEGAS --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) Building on sales to over 50,000 chronic pain sufferers who have tried Quell ® since its launch in June 2015 , NeuroMetrix announced today that it
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (" NeuroMetrix" or the "Company") ( NASDAQ : NURO, NUROW) announced today the pricing of a public offering with expected gross proceeds from the offering of $26.5 million . The offering was priced at $0.70 per share of the Company's common stock
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported increased media attention on the company's Quell ® Wearable Pain Relief Technology ™ , including an in depth report on CBS's Innovation Nation . Highlights include: CBS Innovation Nation - The Medicine-Free Pain
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ is featured in the new Thrive Global commerce platform, including the online store at ThriveGlobal.com and Retail Pop Up Experience in New York City from
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix will speak on using personal connected health for pain, addiction, and healing at the 2016 Connected Health Conference to take place
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that the Company's Quell ® Wearable Pain Relief device is now available on Amazon Launchpad. Amazon Launchpad is a program that makes it easy for startups to launch, market, and distribute their products to
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO, NUROW) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. Dr.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that the CE (Conformité Européenne ) Certificate for Quell ® has been received from TŰV SŰD Product Service GmbH, which is one of the Notified Bodies responsible for reviewing and approving new products.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO,NUROW) announced today that its Quell ® Wearable Pain Relief Technology™ will be featured on the November 26 th episode of The Henry Ford Innovation Nation which airs on the CBS network on Saturday mornings as part of its "CBS
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Quell ® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Society for Regional Anesthesia's Annual Pain Medicine Meeting to be held November 17-19 in San
